Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
Cabinet Reshuffle 2025
AI Startups Boom in Bengaluru
Next Gen Gaming Consoles Unveiled with India Specific Features, Real Time Cloud Play
JNU launches inaugural Indian Knowledge Systems conference featuring more than 100 research presentations
US federal officers deploy tear gas during CA farm immigration raid protests
